NCT01548404 - Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis | Biotech Hunter

Enrollment

109

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions

Atopic Dermatitis

Interventions

DRUG

Placebo

Subcutaneous injection altered between back of arms, abdomen and upper thighs.

DRUG

Dupilumab

Subcutaneous injection altered between back of arms, abdomen and upper thighs.

Trial Locations (21)

Náchod

Svitavy

Ústí nad Labem

Nice

Pierre-Bénite

Toulouse

Berlin

Bonn

Frankfurt

Gera

Heidelberg

Kiel

Münster

Kaposvár

Szeged

Szekszárd

Szolnok

Gdansk

Lodz

Lublin

Warsaw